Phenotypic and functional properties of γδ T Cells from patients with Guillain Barre syndrome

Journal of Neuroimmunology

Volumn 102, Issue 2, 2000, Pages 199-207

  Borsellino, Giovanna ^a   Poccia, Fabrizio ^b   Placido, Roberta ^a   Tramonti, Daniela ^a   Mancino, Giorgio ^b   Luchetti, Sabina ^a   Galgani, Simona ^c   Bonetti, Bruno ^d   Bach, Simona ^a   Cipriani, Barbara ^a,e   Brosnan, Celia F ^e   Battistini, Luca ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Gamma delta T cells; Guillain Barre Syndrome

Indexed keywords

CYTOKINE; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, SURFACE; BLOOD CELLS; CYTOKINES; GUILLAIN-BARRE SYNDROME; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MULTIPLE SCLEROSIS; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0033992328     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00165-4     Document Type: Article

References (53)

1. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barre Syndrome. Ann. Neurol. 27(1):1990;S21-S24.
2. Battistini L., Selmaj K., Kowal C., Ohmen J., Modlin R.L., Raine C.S., Brosnan C.F. Multiple sclerosis: limited diversity of the V delta 2-J delta 3 T-cell receptor in chronic active lesions. Ann. Neurol. 37:1995;198-203.
3. Battistini L., Fisher F., Raine C.S., Brosnan C.F. CD1b expression in multiple sclerosis lesions. J. Neuroimmunol. 67:1996;145-151.
4. Battistini L., Borsellino G., Sawicki G., Poccia F., Salvetti M., Ristori G., Brosnan C.F. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J. Immunol. 159:1997;3723-3730.
5. Ben-Smith A., Gaston J.S., Barber P.C., Winer J.B. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Neurosurg. Psychiatry. 61:1996;362-368.
6. Ben-Smith A., Goodall J.C., Gaston J.S., Winer J.B. Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a gamma delta T cell response in patients with Guillain-Barre syndrome. Clin. Exp. Immunol. 109:1997;121-126.
7. Boullier S., Cochet M., Poccia F., Gougeon M.L. CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons. J. Immunol. 154:1995;1418-1423.
8. Brosnan C.F., Raine C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:1996;243-257.
9. Brossay L., Chioda M., Burdin N., Koezuka Y., Casorati G., Dellabona P., Kronenberg M. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian species. J. Exp. Med. 188:1998;1521-1528.
10. Chien Y.H., Jores R., Crowley M.P. Recognition by γδ T cells. Annu. Rev. Immunol. 14:1996;511-532.
11. Constant P., Davodeau F., Peyrat M.A., Poquet Y., Puzo G., Bonneville M., Fournie J.J. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science. 264:1994;267-270.
12. Cornblath D.R., Griffin D.E., Welch D., Griffin J.W., McArthur J.C. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J. Neuroimmunol. 26:1990;113-118.
13. Dechanet J., Merville P., Berge F., Bone-Mane G., Taupin J.L., Michel P., Joly P., Bonneville M., Potaux L., Moreau J.F. Major expansion of gamma delta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J. Infect. Dis. 179:1999;1-8.
14. Exley M., Porcelli S., Furman M., Garcia J., Balk S. CD161 (NKRP1A costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor α chains. J. Exp. Med. 188:1998;867-876.
15. Freedman M.S., Ruijs T.C.G., Selin L.K., Antel J.P. Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann. Neurol. 30:1991;794-797.
16. Giovannoni G., Hartung H.P. The immunopathogenesis of multiple sclerosis and Guillain-Barre syndrome. Curr. Opin. Neurol. 9:1996;165-177.
17. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells. Science. 279:1998;1737-1740.
18. Hafer-Macko C.E., Sheikh K.A., Li C.Y., Ho T.W., Cornblath D.R., McKhann G.M., Asbury A.K., Griffin J.W. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39:1996;625-635.
19. Harvey G.K., Gold R., Hartung H.P., Toyka K.V. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy. Brain. 118:1995;1263-1272.
20. Hughes R., Atkinson P., Coates P., Hall S., Leibowitz S. Sural nerve biopsies in Guillain-Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle and Nerve. 15:1992;568-575.
21. Jacobs B.C., Van Doorn P.A., Schmitz P.I., Tio-Gillen A.P., Herbrink P., Visser L.H., Hooijkass H., van der Meche F.G. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome. Ann. Neurol. 40:1996;181-187.
22. Khalili-Shirazi A., Hughes R.A.C., Brostoff S.W., Linington C., Gregson N. T cell responses to myelin proteins in Guillain-Barre syndrome. J. Neurol. Sci. 111:1992;200-203.
23. Khalili-Shirazi A., Gregson N.A., Londei M., Summers L., Hughes R.A.C. The distribution of CD1 molecules in inflammatory neuropathy. J. Neurol. Sci. 158:1998;154-163.
24. Linington C., Izumo S., Suzuki M., Uyemura M., Meyermann R., Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the rat in vivo. J. Immunol. 133:1984;1946-1950.
25. Lopez-Botet M., Perez-Villar J.J., Carretero M., Rodriguez A., Melero I. Functional resemblance between the Ig-related NK cell receptors specific for HLA class I molecules and the CD94 C-type lectin. Chem. Immunol. 64:1996;116-134.
26. Miletic V.D., Frank M.M. Complement-immunoglobulin interactions. Curr. Opin. Immunol. 7:1995;41-47.
27. Mingari M.C., Schiavetti F., Ponte M.et al. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA. 93:1996;12433-12438.
28. Ogino M., Orazio N., Latov N. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses. J. Neuroimmunol. 58:1995;77-80.
29. Oomes P.G., Jacobs B.C., Hazenberg M.P.et al. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: evidence of molecular mimicry. Ann. Neurol. 38:1995;170-175.
30. Parker C.M., Groh V., Band H.et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J. Exp. Med. 171:1990;1597-1612.
31. Pette M., Linington C., Gengaroli C.et al. T lymphocyte recognition sites on peripheral nerve myelin P0 protein. J. Neuroimmunol. 54:1994;29-34.
32. Poccia F., Boullier S., Lecoeur H.et al. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. J. Immunol. 157:1996;4449-4461.
33. Poccia F., Cipriani B., Vendetti S., Colizzi V., Poquet Y., Battistini L., Lopez-Botet M., Fournie J.J., Gougeon M.L. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti tumoral responses of polyclonal phosphoantigen-reactive V gamma 9/V delta 2 T lymphocytes. J. Immunol. 159:1997;6009-6017.
34. Poggi A., Zocchi M.R., Costa P., Ferrero E., Borsellino G., Placido R., Galgani S., Salvetti M., Gasperini C., Ristori G., Brosnan C.F., Battistini L. IL-12-Mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of Vδ2+ TCR+ T lymphocytes from healthy donors and multiple sclerosis patients. J. Immunol. 162:1999;4349-4354.
35. Pollard J.D., Westland K.W., Harvey G.K., Jung S., Bonner J., Spies J.M., Toyka K.V., Hartung H.P. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann. Neurol. 37:1995;467-475.
36. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
37. Rees J.H., Soudain S.E., Gregson N.A., Hughes R.A.C. Campylobacter jejuni infection and Guillain-Barre syndrome. New Engl. J. Med. 333:1995;1374-1379.
38. Reyburn H., Mandelboim O., Vales-Gomez M., Sheu G.M., Pazmany L., Davis D.M., Strominger J.L. Human Nk cells: their ligands, receptors and functions. Immunol. Rev. 155:1997;119-125.
39. Saida K. The immunopathology of Guillain-Barre syndrome. Curr. Opin. Neurol. 9:1996;329-333.
40. Sater R.A., Rostami A. Treatment of Guillain-Barre syndrome with intravenous immunoglobulin. Neurology. 51(5):1998;S9-15.
41. Schmidt B., Toyka K.V., Kiefer R., Full J., Hartung H.P., Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle and Nerve. 19:1996;474-487.
42. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraserreid B., Grusby M.J., Tachado T.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NK T cells. Science. 283:1999;225-229.
43. Selmaj K., Brosnan C.F., Raine C.S. Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 88:1991;6452-6456.
44. Stinissen P., Zhang J., Vandevyver C., Hermans G., Raus J. Gamma delta T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination. J. Neuroimmunol. 87:1998;94-104.
45. Sivori S., Vitale M., Sanseverino L., Parolini S., Barbaresi M., Bottino C., Moretta A. Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. Transplant Proc. 28:1996;3199-3203.
46. Tanaka Y., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., Bloom B.R. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature. 375:1995;155-1558.
47. Vicari A.P., Zlotnick A. Mouse NK1.1+ T cells: a new family of T cells. Immunol. Today. 17:1996;71-76.
48. Visser L.H., van der Meche F.G., Meulstee J., Rothbarth P.P., Jacobs B.C., van Schmitz P.I., Doorn P.A. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology. 47:1996;668-673.
49. Vriesendorp F.J., Mishu B., Blaser M.J., Koski C.L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: correlation and prognosis. Ann. Neurol. 34:1993;130-135.
50. Yoshimoto T., Paul W.E. CD4+, NK1.1+ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1994;1285-1295.
51. Yuki N., Handa S., Tai T., Takahashi M., Saito K., Tsujino Y., Taki T. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barre syndrome. J. Neurol. Sci. 130:1995;112-116.
52. Yuki N., Taki T., Handa S. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J. Neuroimmunol. 71:1996;155-161.
53. Zhu J., Link H., Weerth S., Linington C., Mix E., Qiao J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J. Neurol. Sci. 125:1994;132-137.